Comparison of Prognostic Scores for Patients with Colorectal Cancer Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Annals of Surgical Oncology

• Publication date

  2013-08-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1245/s10434-013-3204-2PMID 23975316
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.

  2012cited by this paper
• Patient Selection for Cytoreductive Surgery in Colorectal Peritoneal Carcinomatosis Using Serum Tumor Markers: An Observational Cohort Study

  2012cited by this paper
• Optimizing of preoperative computed tomography for diagnosis in patients with peritoneal carcinomatosis

  2011cited by this paper
• Curative treatment of colorectal peritoneal carcinomatosis: current status and future trends.

  2010cited by this paper
• Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis

  2010cited by this paper
• Impact of the Peritoneal Surface Disease Severity Score on Survival in Patients with Colorectal Cancer Peritoneal Carcinomatosis Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy

  2010cited by this paper
• Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: A multi‐institutional study

  2010cited by this paper
• Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin.

  2009cited by this paper
• Selection of Patients with Colorectal Peritoneal Carcinomatosis for Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy

  2007cited by this paper
• Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

  2006cited by this paper
• Value of 18F-FDG PET in the detection of peritoneal carcinomatosis

  2004cited by this paper
• Peritoneal carcinomatosis from colorectal or appendiceal origin: Correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement

  2004cited by this paper
• Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy

  2004cited by this paper
• Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

  2003cited by this paper
• Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis.

  1996cited by this paper
• Peritonectomy procedures.

  1995cited by this paper

• Pre-operative predictors of completeness of cytoreduction for colorectal peritoneal metastases: a systematic review of radiological, clinicopathological and biomarker-based predictors.

  2025cites this paper
• Peritoneal Cancer Index Dominates Prognosis After CRS–HIPEC for Colorectal Peritoneal Metastases: A Consecutive Single-Centre Cohort with 3-Year Follow-Up

  2025cites this paper
• Predictive factors of non-completion of cytoreductive surgery in colorectal peritoneal metastasis.

  2023cites this paper
• External validation of prognostic scores and comparison of predictive accuracy for patients with colorectal cancer with peritoneal metastases considered for cytoreductive surgery and intraperitoneal chemotherapy

  2023cites this paper
• External validation of COMPASS and BIOSCOPE prognostic scores in colorectal peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

  2022cites this paper
• CMAR_A_277912 5239..5249

  2021cites this paper
• Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC

  2021cites this paper
• Development and Validation of a Nomogram for Predicting Overall Survival In Synchronous Peritoneal Metastasis of Colorectal Cance

  2020cites this paper
• Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Cytoreductive Surgery (CRS) for Colorectal Cancer: Potential for Individualized Care, Review of Current Treatment Trends, Recent Advancements, and a Look into the Future

  2019cites this paper
• Status of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.

  2019cites this paper
• The volume-time index (VTI) is prognostic in patients with colorectal cancer peritoneal metastases undergoing cytoreductive surgery and intraperitoneal chemotherapy.

  2019cites this paper
• Metastatic Colorectal Cancer to the Peritoneum: Current Treatment Options

  2018cites this paper
• CEA to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with colorectal cancer peritoneal carcinomatosis undergoing cytoreduction surgery and intraperitoneal chemotherapy

  2018cites this paper
• Prognostic scores for colorectal cancer with peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

  2018cites this paper
• Radioimmunothérapie préciblée de la carcinose péritonéale par chimie bioorthogonale

  2018cites this paper
• Applications of hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer

  2017cites this paper
• Abordagem Terapêutica da Carcinomatose Peritoneal em doentes com Carcinoma Colorretal

  2017cites this paper
• Unresectability during open surgical exploration in planned cytoreductive surgery and hyperthermic intraperitoneal chemotherapy*

  2016cites this paper
• Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives.

  2016cites this paper
• Preoperative Assessment of Cancer Patients with Peritoneal Metastases for Complete Cytoreduction

  2016cites this paper
• Prognostic Relevance of the Peritoneal Surface Disease Severity Score Compared to the Peritoneal Cancer Index for Colorectal Peritoneal Carcinomatosis

  2016cites this paper
• Development of a Prognostic Nomogram for Patients with Peritoneally Metastasized Colorectal Cancer Treated with Cytoreductive Surgery and HIPEC

  2016cites this paper
• Therapeutic options for peritoneal metastasis arising from colorectal cancer.

  2016cites this paper
• Multimodality treatment strategies have changed prognosis of peritoneal metastases.

  2016cites this paper
• Considerations on the Selection Process for Cytoreductive Surgery and Hyperthermic IntraPeritoneal Chemotherapy for Colorectal Carcinomatosis.

  2015cites this paper
• Peritoneal Carcinomatosis from Colorectal Cancer

  2015cites this paper
• Challenges in the multidisciplinary management of stage IV colon and rectal cancer

  2015cites this paper
• Reply to Letter: "Considerations on the Selection Process for Cytoreductive Surgery and HIPEC for Colorectal Carcinomatosis".

  2015cites this paper
• Management of peritoneal metastases - Basic concepts.

  2015cites this paper
• Theoretical Considerations for Optimal Cytoreductive Surgery Plus Hyperthermic Perioperative Chemotherapy

  2015cites this paper
• Adjuvant HIPEC in Colorectal Cancer

  2014cites this paper
• Immuno-PCI: a proposal for the implementation of "seed and soil" concept in the treatment of peritoneal carcinomatosis from colorectal cancer.

  2014cites this paper
• Optimization of Patient Selection for Surgical Approach to Peritoneal Metastases from Gastrointestinal Cancer Using Cytoreductive Surgery and Perioperative Chemotherapy

  2014cites this paper